Sanofi, AstraZeneca Will Release Additional Doses of Nirsevimab-Alip to Meet ... - Drug Topics

Retrieved on: 2023-12-19 23:05:11

Tags for this article:

Breakthrough therapy

Respiratory syncytial virus

Monoclonal antibodies

Sanofi

Nirsevimab

Respiratory syncytial virus vaccine

Centers for Disease Control and Prevention

Vaccine

Click the tags to see associated articles and topics

Sanofi, AstraZeneca Will Release Additional Doses of Nirsevimab-Alip to Meet ... - Drug Topics. View article details on HISWAI: https://www.drugtopics.com/view/sanofi-astrazeneca-will-release-additional-doses-of-nirsevimab-alip-to-meet-unprecendented-demand

Excerpt

Sanofi, manufacturers of the RSV vaccine nirsevimab-alip (Beyfortus; Sanofi) announced additional dosages of this vaccine would be made available ...

Article found on: www.drugtopics.com

View Original Article